HemaSure Inc. and COBE BCT initiate patent lawsuit with - Pall Corporation
HemaSure Inc. and COBE BCT initiate patent lawsuit with Pall Corporation Stockholm, Sweden - Gambro AB (Stockholm Stock Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that its subsidiary COBE BCT, Inc. and HemaSure, Inc. have filed a lawsuit in Federal Court in Denver to obtain formal confirmation from the Court that the r\LS leukoreduction filter produced by HemaSure and to be distributed by COBE BCT does not infringe any patents owned by Pall Corporation. Pall has recently served a complaint on COBE and HemaSure for a